189 related articles for article (PubMed ID: 10807387)
1. Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma.
Grigsby PW; Siegel BA; Baker S; Eichling JO
JAMA; 2000 May; 283(17):2272-4. PubMed ID: 10807387
[TBL] [Abstract][Full Text] [Related]
2. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
3. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
[TBL] [Abstract][Full Text] [Related]
4. Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions.
Yoshimura M; Tsutsui H; Ikeda N; Koizumi K
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):101-8. PubMed ID: 23474638
[TBL] [Abstract][Full Text] [Related]
5. [Radioiodine therapy of differentiated thyroid cancer: radiologic impact of out-patient treatment with 100 to 150 mCi Iodine-131 activities].
Sapienza MT; Willegaignon J; Ono CR; Watanabe T; Guimarães MI; Gutterres RF; Maréchal MH; Buchpiguel CA
Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):318-25. PubMed ID: 19578592
[TBL] [Abstract][Full Text] [Related]
6. Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members.
Rutar FJ; Augustine SC; Colcher D; Siegel JA; Jacobson DA; Tempero MA; Dukat VJ; Hohenstein MA; Gobar LS; Vose JM
J Nucl Med; 2001 Jun; 42(6):907-15. PubMed ID: 11390555
[TBL] [Abstract][Full Text] [Related]
7. Radiation exposure to family and household members after prostate brachytherapy.
Michalski J; Mutic S; Eichling J; Ahmed SN
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):764-8. PubMed ID: 12788183
[TBL] [Abstract][Full Text] [Related]
8. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy.
Markelewicz RJ; Lorenzen WA; Shusterman S; Grant FD; Fahey FH; Treves ST
Clin Nucl Med; 2013 Aug; 38(8):604-7. PubMed ID: 23797228
[TBL] [Abstract][Full Text] [Related]
9. Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy.
Gates VL; Carey JE; Siegel JA; Kaminski MS; Wahl RL
J Nucl Med; 1998 Jul; 39(7):1230-6. PubMed ID: 9669400
[TBL] [Abstract][Full Text] [Related]
10. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
Parthasarathy KL; Crawford ES
J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749
[TBL] [Abstract][Full Text] [Related]
11. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.
Kusakabe K; Yokoyama K; Ito K; Shibuya H; Kinuya S; Ito M; Higashi T; Togawa T; Koizumi K; Yoshimura M; Uchiyama M; Okamoto T; Kanaya S; Kanaya K; Yoneyama T; Ikebuchi H; Yanagida S; Shibata K; Segawa K; Yamamoto A
Ann Nucl Med; 2012 May; 26(4):370-8. PubMed ID: 22450825
[TBL] [Abstract][Full Text] [Related]
12. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
[TBL] [Abstract][Full Text] [Related]
13. Recommended restrictions after 131I therapy: measured doses in family members.
Mathieu I; Caussin J; Smeesters P; Wambersie A; Beckers C
Health Phys; 1999 Feb; 76(2):129-36. PubMed ID: 9929123
[TBL] [Abstract][Full Text] [Related]
14. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.
Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.
Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ
Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845
[TBL] [Abstract][Full Text] [Related]
16. Iodine-131 in breast milk following therapy for thyroid carcinoma.
Robinson PS; Barker P; Campbell A; Henson P; Surveyor I; Young PR
J Nucl Med; 1994 Nov; 35(11):1797-801. PubMed ID: 7965159
[TBL] [Abstract][Full Text] [Related]
17. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer].
Siekierzyński M
Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040
[TBL] [Abstract][Full Text] [Related]
18. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
19. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy].
Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK
Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042
[TBL] [Abstract][Full Text] [Related]
20. Higher body weight and distant metastasis are associated with higher radiation exposure to the household environment from patients with thyroid cancer after radioactive iodine therapy.
Kuo SF; Ho TY; Liou MJ; Lin KJ; Cheng RC; Chan SC; Huang BY; Ng SC; Liu FH; Chang HY; Hsieh SH; Chiang KC; Chen HY; Lo TY; Lin CL; Lin JD
Medicine (Baltimore); 2017 Sep; 96(35):e7942. PubMed ID: 28858122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]